CLINICAL_TRIALS
trial_result
· 2021-01-13
Clinical Trial Update: Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus [Phase 4]
Summary
Clinical trial investigating whether adding renin-angiotensin system inhibitors to standard antidiabetic therapy improves glycemic control in adults with Type 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nantou Christian Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED